![Sean Tucker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Tucker
Founder at
VAXART, INC.
Net worth: 224 658 $ as of 2026-06-29
Profile
Sean Tucker is the founder of Vaxart, Inc., founded in 2004.
Titles held at Vaxart, Inc. included Director & Vice President-Research from 2012 to 2013, and Chief Scientific Officer & Senior Vice President.
Former jobs include Principal at The Dow Chemical Co., Principal at Systemix, Inc., and Principal at Genteric, Inc. Education history includes undergraduate and doctorate degrees from the University of Washington, and a graduate degree from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXART, INC. 0.15% | 2026-05-25 | 371,336 ( 0.15% ) | 224 658 $ | 2026-06-29 |
Sean Tucker active positions
| Companies | Position | Start |
|---|---|---|
| VAXART, INC. | Founder | 2004-02-29 |
Former positions of Sean Tucker
| Companies | Position | End |
|---|---|---|
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Corporate Officer/Principal | - |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Corporate Officer/Principal | - |
Vaxart, Inc. /Old/
 Vaxart, Inc. /Old/ BiotechnologyHealth Technology Develops technology for oral vaccination against infectious agents | Founder | - |
Training of Sean Tucker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
The Dow Chemical Co.
 The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Vaxart, Inc. /Old/
Vaxart, Inc. /Old/ BiotechnologyHealth Technology Develops technology for oral vaccination against infectious agents | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genteric, Inc.
Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Health Technology |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
- Stock Market
- Insiders
- Sean Tucker
